Vicarious Surgical Inc. (NYSE:RBOT – Get Free Report) shares rose 27.7% during mid-day trading on Wednesday . The company traded as high as $3.66 and last traded at $3.3210. Approximately 1,188,777 shares were traded during mid-day trading, an increase of 1,415% from the average daily volume of 78,467 shares. The stock had previously closed at $2.60.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on the company. Piper Sandler lowered their price target on Vicarious Surgical from $8.50 to $7.00 and set a “neutral” rating on the stock in a report on Wednesday, August 13th. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised Vicarious Surgical to a “sell” rating in a research note on Saturday, September 13th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $7.00.
View Our Latest Research Report on RBOT
Vicarious Surgical Stock Performance
Vicarious Surgical (NYSE:RBOT – Get Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, topping analysts’ consensus estimates of ($2.37) by $0.46. Sell-side analysts predict that Vicarious Surgical Inc. will post -10.89 earnings per share for the current year.
Institutional Investors Weigh In On Vicarious Surgical
Several institutional investors and hedge funds have recently modified their holdings of the business. Dimensional Fund Advisors LP boosted its holdings in Vicarious Surgical by 22.1% in the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after purchasing an additional 3,615 shares in the last quarter. Connective Capital Management LLC acquired a new stake in shares of Vicarious Surgical in the third quarter worth about $169,000. Finally, DNB Asset Management AS boosted its stake in shares of Vicarious Surgical by 12.1% during the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after acquiring an additional 3,154 shares in the last quarter. Institutional investors and hedge funds own 47.27% of the company’s stock.
About Vicarious Surgical
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Featured Articles
- Five stocks we like better than Vicarious Surgical
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- What Are Growth Stocks and Investing in Them
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- How to Invest in Small Cap Stocks
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
